Her2 Positive Breast Cancer: 5 Treatment Options You Should Know

Her2 positive breast cancer is characterized by an overexpression of the HER2 protein that promotes cancer cell growth. This aggressive form of breast cancer affects approximately 20% of breast cancer patients but has seen significant treatment advances in recent years.

What is Her2 Positive Breast Cancer?

Her2 positive breast cancer is a type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). This protein promotes the growth of cancer cells. In about one of every five breast cancers, the cancer cells have a gene mutation that makes an excess of the HER2 protein.

HER2-positive breast cancers tend to be more aggressive than other types of breast cancer. They grow faster and are more likely to spread to other parts of the body. However, treatments that specifically target HER2 have dramatically improved the prognosis for patients with this diagnosis. Understanding your HER2 status is crucial because it helps determine the most effective treatment approach for your specific type of breast cancer.

How Her2 Positive Breast Cancer is Diagnosed

Diagnosing Her2 positive breast cancer involves several steps beyond the initial detection of a breast tumor. After a biopsy, the tissue sample is tested to determine if the cancer cells are producing too much of the HER2 protein or have too many copies of the HER2 gene.

Two main tests are commonly used for HER2 detection. The immunohistochemistry (IHC) test measures the amount of HER2 protein on the surface of the cancer cells, with scores ranging from 0 to 3+. Scores of 0 or 1+ are considered HER2-negative, while 3+ is HER2-positive. A score of 2+ is borderline, requiring further testing.

The fluorescence in situ hybridization (FISH) test looks for extra copies of the HER2 gene in the cancer cells. This test is often used to confirm borderline IHC results. Getting an accurate diagnosis is essential as it directly influences treatment decisions and overall prognosis.

Treatment Options and Medication Comparison

Treatment for Her2 positive breast cancer typically involves a combination of approaches, with HER2-targeted therapies playing a central role. These therapies have revolutionized outcomes for patients with this aggressive form of breast cancer.

The main categories of treatment include:

HER2-targeted therapies - Medications that specifically target the HER2 protein
Chemotherapy - Often used in combination with HER2-targeted treatments
Surgery - To remove the tumor and possibly affected lymph nodes
Radiation therapy - To destroy any remaining cancer cells after surgery
Hormonal therapy - If the cancer is also hormone receptor-positive

Here's a comparison of major HER2-targeted medications currently available:

Medication	Administration	Common Use	Notable Features
Herceptin (trastuzumab)	Intravenous or injection	Early and metastatic stages	First approved HER2-targeted therapy
Perjeta (pertuzumab)	Intravenous	Often combined with Herceptin	Blocks HER2 in a different way than Herceptin
Kadcyla (T-DM1)	Intravenous	After treatment with Herceptin	Antibody-drug conjugate that delivers chemotherapy directly to HER2+ cells
Enhertu (trastuzumab deruxtecan)	Intravenous	Advanced metastatic disease	Newer antibody-drug conjugate with strong results
Nerlynx (neratinib)	Oral pill	Extended adjuvant therapy	Often used after completing Herceptin therapy

The selection of treatments depends on several factors, including the stage of cancer, previous treatments, overall health, and personal preferences. Your oncology team will create a personalized treatment plan based on your specific situation.

Benefits and Side Effects of Her2 Targeted Therapies

HER2-targeted therapies have dramatically improved outcomes for patients with Her2 positive breast cancer. Before these treatments were available, HER2-positive breast cancer had a poorer prognosis compared to other types. Today, many patients respond well to these targeted approaches.

The key benefits of HER2-targeted therapies include:

Significant improvement in survival rates
Reduced risk of recurrence in early-stage disease
Effective tumor shrinkage in metastatic disease
Ability to target cancer cells while sparing healthy cells
Option to combine with other treatments for enhanced effectiveness

However, these medications can cause side effects that patients should be aware of. Breastcancer.org provides comprehensive information about these side effects, which may include:

Heart problems - Particularly with trastuzumab (Herceptin), which may cause decreased heart function
Infusion reactions - Including fever, chills, nausea during or shortly after receiving the medication
Skin problems - Rash, dry skin, or nail changes
Diarrhea - Especially common with neratinib (Nerlynx)
Fatigue - A common side effect across most cancer treatments
Low blood cell counts - Particularly with antibody-drug conjugates like Kadcyla and Enhertu

Regular monitoring during treatment helps manage these side effects effectively. Your healthcare team will conduct periodic heart function tests and other assessments to ensure the benefits of treatment continue to outweigh the risks.

Living With Her2 Positive Breast Cancer

Being diagnosed with Her2 positive breast cancer can be overwhelming, but many resources are available to help patients navigate their journey. Support groups, both in-person and online, provide valuable emotional support and practical advice from others who understand the experience firsthand.

Cancer Support Community offers free support services, education, and resources for cancer patients and their families. Their programs include specialized information about HER2-positive breast cancer management and coping strategies.

Lifestyle modifications may also play a supportive role during and after treatment. While they don't replace medical treatment, healthy habits can help manage side effects and improve overall wellbeing:

Maintaining a balanced diet rich in fruits, vegetables, and whole grains
Engaging in regular physical activity as tolerated and approved by your healthcare team
Practicing stress reduction techniques like meditation, yoga, or deep breathing
Getting adequate rest and prioritizing sleep quality
Staying connected with family and friends for emotional support

Many patients also find that working with a patient navigator helps them coordinate appointments, understand treatment options, and access financial resources. These professionals can guide you through the healthcare system and ensure you receive timely, appropriate care.

Remember that treatment approaches continue to evolve, with research organizations like the Breast Cancer Research Foundation funding studies to develop even more effective therapies. Staying informed about new developments through reliable sources can help you make the best decisions about your care in partnership with your healthcare team.

Conclusion

Her2 positive breast cancer, while aggressive, now has more treatment options than ever before. The development of targeted therapies has transformed what was once considered one of the most challenging forms of breast cancer into one with many effective treatment pathways. If you or a loved one has received this diagnosis, work closely with a specialized oncology team to create a personalized treatment plan. With ongoing advances in treatment approaches and supportive care, many patients with Her2 positive breast cancer can achieve positive outcomes and maintain a good quality of life. Remember that each person's cancer journey is unique, and finding the right combination of medical treatment and support resources is key to navigating this challenging diagnosis.

Citations

This content was written by AI and reviewed by a human for quality and compliance.